LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 47 filers reported holding LYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $71,892 | -90.8% | 259,820 | +105.9% | 0.00% | – |
| Q1 2024 | $784,840 | +37.2% | 126,180 | +15.6% | 0.00% | – |
| Q4 2023 | $572,103 | +53.9% | 109,180 | +14.8% | 0.00% | – |
| Q3 2023 | $371,763 | +62.2% | 95,080 | +70.5% | 0.00% | – |
| Q2 2023 | $229,256 | +194.7% | 55,780 | +48.4% | 0.00% | – |
| Q1 2023 | $77,791 | -67.0% | 37,580 | -50.0% | 0.00% | – |
| Q4 2022 | $236,002 | +34.1% | 75,160 | +114.5% | 0.00% | – |
| Q3 2022 | $176,000 | -8.8% | 35,043 | +2.3% | 0.00% | – |
| Q2 2022 | $193,000 | -82.7% | 34,243 | -64.4% | 0.00% | – |
| Q1 2021 | $1,115,000 | +26.0% | 96,246 | +24.0% | 0.00% | – |
| Q4 2020 | $885,000 | +73.9% | 77,646 | +70.6% | 0.00% | – |
| Q3 2020 | $509,000 | +5.8% | 45,506 | +7.2% | 0.00% | – |
| Q2 2020 | $481,000 | – | 42,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,222,560 | $12,955,000 | 0.26% |
| Ikarian Capital, LLC | 422,338 | $1,698,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 520,544 | $2,093,000 | 0.07% |
| Clearline Capital LP | 119,924 | $482,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,900 | $269,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,516 | $155,000 | 0.00% |
| Pentwater Capital Management LP | 60,000 | $241,000 | 0.00% |
| Worth Asset Management, LLC | 650 | $3,000 | 0.00% |
| Close Asset Management Ltd | 7,000 | $30,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $2,000 | 0.00% |